Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 09/29 10:00:00 pm
92.78 USD   -3.38%
09/22 NASDAQ 100 MOVE : Bmrn, bbby
09/21DJSAREPTA THERAPE : to Sell Up to $225 Million of Stock
09/21 BIOMARIN PHARMA : Reviews Status of Exon 51 Composition of Matter an..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/23/2016 09/26/2016 09/27/2016 09/28/2016 09/29/2016 Date
97.4(c) 95.87(c) 97.05(c) 96.03(c) 92.78 Last
812 600 823 786 1 183 690 1 194 396 1 046 414 Volume
-0.05% -1.57% +1.23% -1.05% -3.38% Change
More quotes
Financials ($)
Sales 2016 1 129 M
EBIT 2016 -764 M
Net income 2016 -607 M
Debt 2016 144 M
Yield 2016 -
Sales 2017 1 341 M
EBIT 2017 -160 M
Net income 2017 -200 M
Debt 2017 243 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 14,7x
EV / Sales2017 12,4x
Capitalization 16 400 M
More Financials
Company
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.It operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's products include... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
09/29 BIOMARIN PHARMACEUTICAL : Sarepta Therapeutics Announces Favorable USPTO Decisio..
09/22 NASDAQ 100 MOVERS : Bmrn, bbby
09/21DJSAREPTA THERAPEUTICS : to Sell Up to $225 Million of Stock
09/21 BIOMARIN PHARMACEUTICAL : Reviews Status of Exon 51 Composition of Matter and Me..
09/19 BIOMARIN PHARMACEUTICAL : Announces Pricing of Public Offering of Common Stock
09/19 BIOMARIN PHARMACEUTICAL : Announces Public Offering of Common Stock
09/15 BioMarin Announces EMA Validation of Brineura™ (Cerliponase Alfa) Marke..
09/08 BioMarin Announces Two Oral and 16 Poster Presentations at Society for the St..
09/07 BIOMARIN PHARMACEUTICAL : Announces Update to Brineura (Cerliponase Alfa) Progra..
09/07 BIOMARIN PHARMACEUTICAL INC. (NASDAQ : BMRN)’s Setback Isn’t Really ..
More news
Sector news : Generic Pharmaceuticals
09/29DJGLAXOSMITHKLINE : Appoints New Consumer Healthcare Chief
09/29DJNOVO NORDISK A/S : to Cut 1,000 Jobs Amid Growing Competition -- Update
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
09/28 Monsanto ally Novozymes sees opportunity, risk in Bayer merger
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
09/26 Summit's ezutromid Fast Track'd for Duchenne muscular dystrophy
09/22 BEST NEAR-TERM PRICE GAINS AHEAD FOR : Biotech Stocks
09/22 Sarepta Turns New Leverage Point For Aspiring Biotechs
09/20 Sarepta prevails over BioMarin in patent fight over exon skipping; shares up ..
09/19 Sarepta to charge $300K for yearly course of Exondys 51
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends BIOMARIN PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 119 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Jacques Bienaimé Chairman & Chief Executive Officer
Daniel K. Spiegelman Chief Financial Officer & Executive Vice President
Henry J. Fuchs Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux Chief Information Officer & Vice President
Pierre Lapalme Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..-8.33%16 400
SUN PHARMACEUTICAL IND..-5.88%27 667
OTSUKA HOLDINGS CO LTD6.81%25 344
ONO PHARMACEUTICAL CO...-34.26%16 623
ASPEN PHARMACARE HOLDI..1.51%10 610
TAISHO PHARMACEUTICAL ..22.88%9 258
More Results